Fluorescent In Situ Hybridization Service

Posted by Teddy Morini on January 30th, 2019

Fluorescent In Situ Hybridization Service — the Most Reliable Choice in Histology Service Provided by Creative Bioarray

New York, January 11th, 2019 -- Creative Bioarray is an innovative biotechnology company whose major mission is to develop unique technologies that provide high-quality products and satisfactory services to scientists around the world and to facilitate researches in life science. Our company provides a wide range of services and products, and our featured Services include histology services, cell services, cell-based drug discovery and biosample services etc. Among which, fluorescent in situ hybridization service (FISH), which is a subcategory of histology services has recently entered into a new era.

With years of experience and in-depth knowledge, our company offers our customers fluorescence in situ hybridization (FISH) services ranging from standardized tests for validation assays to custom development of new assays.

Creative Bioarray's FISH services have some unique technologies to establish a proprietary solution for slide preparation that enhances the sensitivity and signal of a variety of FISH applications as followings:

Cellular chromosome FISH (interphase, metaphase and cultured cells)

Tissue chromosome FISH (formalin-fixed, paraffin-embedded tissue or cell slide)

RNA-FISH (intracellular RNA localization, RNA processing, quantification)

Recently, FISH has entered the field of dermatology to help assess blurred melanocyte lesions. Creative Bioarry dedicates itself to researching FISH technology and its advantages and limitations in dermatology, with a focus on melanoma. For example, a large number of recurrent cytogenetic abnormalities have been found in melanomas by comparative genomic hybridization (CGH); these recurrent abnormalities serve as excellent candidates for FISH probes. Other applications include using the IGH/MAF Dual Fusion Probe to determine whether the c-MAF gene is amplified in primary tumor samples, diagnose or predict prostate cancer metastasis, and to identify trends in bone metastases in other organs etc.

In the meantime, Creative Bioarray also offers the most comprehensive list of FISH probes to quickly identify various chromosomal aberrations in the genome. Our company’s FISH probes are designed using proprietary algorithms developed by our experts to offer a wide range of label options with excellent sensitivity and specificity . Several selected specific tests include but are not limited to:

Acute myeloid leukemia

Acute lymphoblastic leukemia

Chronic lymphoblastic leukemia

Chronic myelomonocytic leukemia

Mantle cell lymphoma

MALT lymphoma

more info on url：

About Creative Bioarray

Creative Bioarry is an innovative bio-products research and development service company founded in 2005 with its headquarter located in New York, USA. Relaying on profound international resources and experienced experts, Creative Bioarry provides excellent products and services for new drug development.